Healthstream (HSTM) Common Equity (2010 - 2026)

Healthstream (HSTM) has 17 years of Common Equity data on file, last reported at $352.0 million in Q1 2026.

• On a quarterly basis, Common Equity fell 2.98% year-over-year to $352.0 million in Q1 2026; TTM through Mar 2026 was $352.0 million, a 2.98% decrease from a year earlier, with the FY2025 full-year figure at $354.0 million, down 1.48% from the prior year.
• Common Equity for Q1 2026 stood at $352.0 million, down from $354.0 million in the prior quarter.
• Over the last five years, Common Equity for HSTM reached as high as $362.8 million in Q1 2025 and fell as low as $322.6 million in Q1 2022.
• Historically, Common Equity has averaged $344.2 million across 5 years, with a median of $344.9 million in 2024.
• Across the five-year window, Common Equity declined 4.23% in 2022 and rose 5.46% in 2024, its largest moves.
• Year by year, Common Equity stood at $334.1 million in 2022, then gained by 2.0% to $340.8 million in 2023, then advanced by 5.46% to $359.4 million in 2024, then dropped by 1.48% to $354.0 million in 2025, then declined by 0.57% to $352.0 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were $352.0 million in Q1 2026, $354.0 million in Q4 2025, and $349.2 million in Q3 2025.